Alternative Names
anti-VISTA antibody research-grade biosimilar; CI 8993 research-grade biosimilar; CI-8993 research-grade biosimilar; JNJ 61610588 research-grade biosimilar; JNJ-61610588 research-grade biosimilar; Onvatilimab research-grade biosimilar; Onvatilimab (USAN/INN) research-grade biosimilar; VSIR antibody; C10orf54 antibody; SISP1 antibody; VISTA antibody; PP2135 antibody; UNQ730/PRO1412 antibody;V-type immunoglobulin domain-containing suppressor of T-cell activation antibody; Platelet receptor Gi24 antibody; Stress-induced secreted protein-1 antibody; Sisp-1 antibody; V-set domain-containing immunoregulatory receptor antibody; V-set immunoregulatory receptor antibody
Immunogen
Recombinant Human VSIR protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.